Boston Scientific (BSX)
(Delayed Data from NYSE)
$98.98 USD
-0.89 (-0.89%)
Updated Sep 16, 2025 03:59 PM ET
After-Market: $98.98 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth D Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Boston Scientific Corporation has a PEG ratio of 2.53 compared to the Medical - Products industry's PEG ratio of 2.33.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BSX 98.98 -0.89(-0.89%)
Will BSX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BSX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BSX
Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors
BSX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Reasons to Retain Avanos Medical Stock in Your Portfolio Now
Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System
Cardinal Health Expands At-Home Solutions With New Texas Facility
Other News for BSX
Noteworthy Tuesday Option Activity: BSX, FDX, PYPL
Is BSX heading for a slide? Fell Below 200 Day Moving Average shows up after sliding 2.77%
Interesting BSX Put And Call Options For January 2028
Boston Scientific’s Strong Growth Prospects and Strategic Initiatives Reinforce Buy Rating
Boston Scientific Breaks Below 200-Day Moving Average - Notable for BSX